The Lancet HIV

The Lancet HIV will build on The Lancet’s rich history of publishing HIV/AIDS research to provide a reliable foundation for advocacy and for programmatic and political change. The journal will publish the best translational, epidemiological, clinical, and implementation research. Most importantly, the journal will aim to unify these disciplines across a single vision for the health of those living with HIV. The Lancet HIV has been founded on two clear principles. First, the task of defecting HIV has not been accomplished and the journal will work in partnership with others to accelerate our response immediately. Second, The Lancet HIV is a new journal intending to reposition HIV/AIDS for a new era of sustainable development. We invite you to join us in this two-fold mission.

Editor in Chief: Peter Hayward
2024
Online Only
The Lancet HIV
Global Print Circulation
Online Only
Avg. Global Monthly Visits
34,849
Avg. Global Monthly Unique Visitors
12,928
Avg. Global Monthly Page Views
19,091
Avg. Global eTOC Distribution
53,375
Circulation updated on 1st July, 2023, based on 12-month monthly average July 2022-June 2023 eTOC Metrics: 12 Month Average of eTOC sends - July 2022 to June 2023 Monthly average web metrics based on the period of July 2022 to June 2023

Contacts

Display Advertising

Recruitment Advertising

Have a question or need assistance?

Contact us now and a Sales Representative will be in touch.